Bridging Study on Safety and Immunogenicity of an Intramuscular Inactivated, Split Virion Swine-Origin A/H1N1 Influenza Non-Adjuvanted Vaccine in Healthy Adults in India.
Phase of Trial: Phase III
Latest Information Update: 24 Aug 2016
At a glance
- Drugs Influenza A virus vaccine-H1N1 (Primary)
- Indications Influenza A virus H1N1 subtype
- Focus Adverse reactions; Pharmacodynamics; Registrational
- Sponsors Sanofi; sanofi pasteur
- 29 Jan 2010 Planned end date changed from 1 Dec 2010 to 1 Sep 2010 as reported by ClinicalTrials.gov.
- 29 Jan 2010 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
- 28 Jan 2010 New trial record